MedTrace Logo

Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease

NCT03577691 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2019-07-23

No results posted yet for this study

Summary

The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without training. Subjects in each group will be further randomized to 1) subjects receiving pretest surveys; and 2) subjects that do not receive pretest surveys.

Conditions

Interventions

OTHER

Training for use of web based Decision Aid

Subjects will be guided during a 30 minutes training session to use the website

OTHER

No training for use of web based Decision Aid

Subjects will not be guided during a 30 minutes training session to use the website

OTHER

Pretest surveys and posttest surveys

Subjects will be randomized to one of two groups initially: Those who do not receive training for the decision aid and those who are trained to navigate the decision aid. subjects in each group will be randomized to complete pre test and posttest surveys or only posttest surveys that will take 15 mts of time

OTHER

Only posttest surveys

Subjects will be randomized to one of two groups initially: Those who do not receive training for the decision aid and those who are trained to navigate the decision aid. subjects in each group will be randomized to complete pretest and posttest surveys or only posttest surveys.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Lakshmanan Krishnamurti, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-03
Primary Completion
2019-07-03
Completion
2019-07-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03577691 on ClinicalTrials.gov